Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-18 Purchase | 2021-03-19 1:07 pm | PAVmed Inc. | PAVM | Aklog Lishan Pavilion Venture Partners LLC Chairman and CEO 10% Owner | 7,500 | $4.3098 | $32,324 | 5,587,066 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-07 Option Award | 2024-05-08 4:00 pm | N/A N/A | Lucid Diagnostics Inc. | LUCD | Aklog Lishan Chief Executive Officer | 400,000 | $0 | 1,166,627 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-18 5:53 pm | N/A 2032-05-17 | CONTRAFECT Corp | CFRX | Aklog Lishan Director | 42,000 | $3.35 | 42,000 (Direct) | View |
| 2022-03-28 Tax Withholding | 2022-04-11 6:24 pm | N/A N/A | PAVmed Inc. | PAVM | Aklog Lishan Chairman and CEO | 79,636 | $1.18 | 4,657,430 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 8:13 pm | N/A 2032-02-18 | Lucid Diagnostics Inc. | LUCD | Aklog Lishan Chief Executive Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 8:13 pm | N/A 2032-02-18 | PAVmed Inc. | PAVM | Aklog Lishan Chairman and CEO 10% Owner | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-10 8:06 pm | N/A N/A | Lucid Diagnostics Inc. | LUCD | Aklog Lishan Chief Executive Officer | 60,000 | $0 | 624,400 (Direct) | View |
Ownership | 2021-10-13 9:25 pm | N/A N/A | Lucid Diagnostics Inc. | LUCD | Aklog Lishan Chief Executive Officer | 0 | $0 | 564,400 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 7:36 pm | N/A 2031-05-18 | CONTRAFECT Corp | CFRX | Aklog Lishan Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 5:09 pm | N/A N/A | PAVmed Inc. | PAVM | Aklog Lishan Chairman and CEO 10% Owner | 150,000 | $0 | 5,737,066 (Direct) | View |
| 2020-12-23 Other | 2020-12-28 7:48 pm | N/A N/A | Viveon Health Acquisition Corp. | VHAQ | Aklog Lishan Director | 27,000 | $0 | 54,000 (Direct) | View |
Ownership | 2020-12-28 06:37 am | N/A N/A | Viveon Health Acquisition Corp. | VHAQ | Aklog Lishan Director | 0 | $0 | 0 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 4:51 pm | N/A 2030-06-14 | CONTRAFECT Corp | CFRX | Aklog Lishan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 5:25 pm | N/A N/A | PAVmed Inc. | PAVM | Aklog Lishan Pavilion Venture Partners LLC Chairman and CEO 10% Owner | 250,000 | $0 | 5,579,566 (Direct) | View |